Optimizing therapy for heart failure patients: cardiac resynchronization and defibrillator therapy
Related Experiment Video
Updated: Jul 16, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Scot B Jensen1, Catherine A Galvin, Brenda Thompson
1McKay Dee Cardiology, Ogden, Utah 84403, USA. scot.jensen@ihc.com
Abstract:
Heart failure continues to be diagnosed at unprecedented rates. It is essential that the affiliated professional, including the nurse practitioner, clinical nurse specialist, and physician assistant, be aware of the current treatments and technology that improve symptoms and reduce mortality rates in patients with heart failure. Medications remain critical in reducing symptoms. New clinical trial data on cardiac resynchronization therapy and cardiac resynchronization therapy with defibrillation reveal improved mortality and quality of life in patients already on optimal drug therapy. This article addresses current treatment strategies with drugs and devices, summarizes therapy efficacy based on clinical trial data, and provides a case study illustrating a typical patient who could benefit from the addition of device therapy. Through awareness of current guidelines and advocacy for the patient, nurses and affiliated professionals have an essential role in reducing mortality and improving outcomes for heart failure patients.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy III: Hypertrophic Cardiomyopathy

